Decision in the case of Hamad Abbas Janahi

The International Tennis Federation announced today that Hamad Abbas Janahi has been found to have committed an Anti-Doping Rule Violation under Article 2.1 of the Tennis Anti-Doping Programme (presence of a Prohibited Substance in a Player’s Sample).

Mr Janahi, a 24 year-old player from UAE, provided a urine sample on 21 February 2015 in association with his participation in the 2015 Dubai Duty Free Tennis Championships event (the "Dubai event") held in Dubai, UAE. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain a metabolite of methylphenidate and 1,3-dimethylbutylamine, which are Prohibited Substances under section S6(b) (Stimulants) of the 2015 WADA List of Prohibited Substances and Prohibited Methods, and are therefore also prohibited under the Tennis Anti-Doping Programme (the "Programme"). Mr Janahi was therefore charged with an Anti-Doping Rule Violation under Article 2.1 of the Programme.

Mr Janahi’s commission of an Anti-Doping Rule Violation under Article 2.1 of the Programme was confirmed, and it was determined that he is suspended from participation for a period of two years, commencing on 27 May 2015, and so ending at midnight on 26 May 2017. It was also determined that his results at the Dubai event should be disqualified, with resulting forfeiture of the ranking points and prize money that he won at those events.

The Tennis Anti-Doping Programme is a comprehensive and internationally recognised drug-testing programme that applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are tested for substances prohibited by the World Anti-Doping Agency and, upon a finding that an Anti-Doping Rule Violation has been committed, sanctions are imposed in accordance with the requirements of the Tennis Anti-Doping Programme and World Anti-Doping Code. More background information on the Programme, sanctions, tennis statistics and related information can be found at www.itftennis.com/antidoping.

For more information, please contact:

ITF Communications

Tel: +44 (0)20 8392 4632

Email: communications@itftennis.com

20 Years at #1: Your best source of news about the Olympics is www.aroundtherings.com, for subscribers only